Recently in AUA Category

The know error® system for prostate biopsies is set to exhibit at the upcoming joint meeting of the New England and Mid-Atlantic Sections of the AUA. The meeting runs from November 3-6, 2011 at the Walt Disney World Swan Hotel in Orlando, FL. Click here for more information on this meeting.

Know Error develops and markets the know error® system which utilizes bar coding, forensic principles and DNA matching to confirm that the biopsy samples being evaluated belong to the patient being diagnosed. Available for a diverse range of tissue types, including prostate, the know error® system brings new levels of patient safety and diagnostic accuracy to the biopsy evaluation process.

Since the company's launch in 2009, hundreds of physicians in a variety of specialties, including urology, have incorporated the know error® system as a standard for their patient care. To learn more about the know error® system for prostate biopsies, visit our website www.knowerror.com.

The know error® system for prostate biopsies is set to exhibit at the North Central Section of the AUA's annual meeting which runs from October 18-22, 2011. This meeting will take place at The Westin Mission Hills in Rancho Mirage, CA. To find out more about this meeting, click here.

Know Error develops and markets the know error® system which utilizes bar coding, forensic principles and DNA matching to confirm that the biopsy samples being evaluated belong to the patient being diagnosed. Available for a diverse range of tissue types, including prostate, the know error® system brings new levels of patient safety and diagnostic accuracy to the biopsy evaluation process.

Since the company's launch in 2009, hundreds of physicians in a variety of specialties, including urology, have incorporated the know error® system as a standard for their patient care. To learn more about the know error® system for prostate biopsies, visit our website www.knowerror.com.

The know error® system for prostate biopsies is set to exhibit at three upcoming meetings of the American Urological Association (AUA).

The first is the 90th Annual Meeting of the South Central Section of the AUA being held September 14-16, 2011 at the JW Marriott San Antonio Hill Country. Click here to learn more about this meeting. Look for us at Booth #313.

The North Central Section of the AUA's Annual Meeting comes next and runs from October 18-22, 2011. This meeting will take place at The Westin Mission Hills in Rancho Mirage, CA. To find out more about this meeting, click here.

Wrapping up the AUA meetings for 2011 is the joint meeting of the New England and Mid-Atlantic Sections of the AUA. The joint meeting is set for November 3-6, 2011 at the Walt Disney World Swan Hotel in Orlando, FL. Click here for more information on this meeting.

Launched in the spring of 2009, the know error® system for prostate biopsies brings a new standard of patient safety and diagnostic accuracy to the biopsy evaluation process. Through our innovative use of forensic chain of custody principles and DNA testing, the know error® system confirms that the biopsy samples being evaluated belong to the patient being diagnosed.

To learn more about the know error® system for prostate biopsies, visit our website www.knowerror.com.

The know error® system for prostate biopsies will be showcased at the Annual Meeting of the Western Section of the American Urological Association (AUA). The meeting is being held August 21-25, 2011 at the Westin Bayshore in Vancouver, BC. Look for us at Booth #57.

The know error® system for prostate biopsies brings a new standard of patient safety and diagnostic accuracy to the biopsy evaluation process. Through our innovative use of forensic chain of custody principles and DNA testing, the know error® system confirms that the biopsy samples being evaluated belong to the patient being diagnosed. Since its launch in 2009, the system has identified DNA non-matches in more than 1% of the patient cases for whom testing has been performed.

To learn more about the know error® system for prostate biopsies, visit our website www.knowerror.com.

The know error® system for prostate biopsies will be exhibiting this week at the Annual Meeting of the AUA. The meeting kicks off this Saturday, May 14 and lasts through Thursday May 19. The meeting is being held at Walter E. Washington Convention Center in Washington, DC. Look for us at booth #3150. For more information on this meeting, click here.

The know error® system, introduced in the spring of 2009, provides an effective way to establish specimen provenance. Through the use of DNA Specimen Provenance Assignment (DSPA) and bar code technology, the know error® system brings new levels of safety and accuracy to the biopsy evaluation process.

For more information on the know error® system for prostate biopsies, visit our website www.knowerror.com. 

The know error® system for prostate biopsies is being showcased at the Annual Meeting of the American Urological Association (AUA). The meeting takes place May 14-19, 2011 Walter E. Washington Convention Center in Washington, DC. Look for us at booth #3150. For more information on this meeting, click here.

The know error® system, introduced in the spring of 2009 by Diagnostic ID, LLC, provides an effective way to establish specimen provenance. Through the use of DNA Specimen Provenance Assignment (DSPA) and bar code technology, the know error® system brings new levels of safety and accuracy to the biopsy evaluation process.

This innovative system dramatically reduces the incidence of Specimen Provenance Complications (SPC) which may arise due to instances of specimen transposition, foreign cell contamination, and patient misidentification that occur in clinical or anatomical pathology. By performing DNA testing of biopsy tissue samples PRIOR to any treatment taking place, the know error® system virtually eliminates any adverse patient outcomes due to SPC.

For more information about the know error® system for prostate biopsies, please visit our website www.knowerror.com.

The know error® system for prostate biopsies is being showcased at the 75th Annual Meeting of the Southeastern Section of the American Urological Association (AUA). The meeting is being held March 17-20, 2011 at the Marriott New Orleans. For more information on this meeting, click here.

The know error® system, introduced in the spring of 2009 by Diagnostic ID, LLC, provides an effective way to establish specimen provenance. Through the use of DNA Specimen Provenance Assignment (DSPA) and bar code technology, the know error® system brings new levels of safety and accuracy to the biopsy evaluation process.

This innovative system dramatically reduces the incidence of Specimen Provenance Complications (SPC) which may arise due to instances of specimen transposition, foreign cell contamination, and patient misidentification that occur in clinical or anatomical pathology. By performing DNA testing of biopsy tissue samples PRIOR to any treatment taking place, the know error® system virtually eliminates any adverse patient outcomes due to SPC.

For more information about the know error® system for prostate biopsies, please visit our website www.knowerror.com.

The know error® system for prostate biopsies is being showcased this week at the Annual Meeting of the South Central Section of the American Urological Association (AUA). The meeting is being held October 14-17, 2009, at the Camelback Inn, JW Marriott Resort, in Scottsdale, Arizona. Look for us at Booth #151 in the exhibit hall. 

Through the use of DNA Specimen Provenance Assignment (DSPA) and bar code technology, the know error® system brings new levels of safety and accuracy to the biopsy evaluation process. This innovative system dramatically reduces the incidence of Specimen Provenance Complications (SPC) enhancing patient safety and diagnostic accuracy.

The know error® system uncovers SPCs by matching tissue from a positive biopsy result to a reference sample taken from the patient via a simple cheek swab to confirm that the tissue belongs to the patient. By performing DNA matching prior to treatment, the know error® system virtually eliminates diagnostic mistakes due SPC.

For more information about the know error® system for prostate biopsies, please visit our website www.knowerror.com.

The know error® system for prostate biopsies will be showcased at several upcoming Section Meetings of the American Urological Association (AUA). The first stop is the Annual Meeting of the New England Section of the AUA, September 24-27, 2009, at the Rennaissance Hotel in Washington, DC. Look for us at Booth #23 in the exhibit hall. 

Through the use of DNA Specimen Provenance Assignment (DSPA) and bar code technology, the know error® system brings new levels of safety and accuracy to the biopsy evaluation process. This innovative system virtually eliminates the possibililty of adverse patient outcomes due to Specimen Provenance Complications (SPC). By performing DSPA prior to treatment, the know error® system assures that SPCs will be detected prior to any unnecessary surgeries or treatment plans.

For more information about the know error® system for prostate biopsies, visit our website at www.knowerror.com.

A study published in the Journal of Urology (October 2007) suggested that the medical community may be ready for a "DNA Timeout" utilizing forensic DNA to prevent biopsy switching errors that may result in adverse patient outcomes. The study, conducted by Drs. John Pfeifer, Stephen Raab, and Eric Suba, concluded: "Patient identification errors among prostate needle biopsies may be difficult to entirely prevent through optimization of work flow processes. A DNA time-out, whereby DNA polymorphic microsatellite analysis is used to confirm patient identification before radiation therapy or radical surgery, may eliminate patient identification errors among needle biopsies."

As identified in this study, a process often referred to as DNA "fingerprinting" has been advocated to catch those errors which are undetected by existing quality systems, even those systems which adopt sophisticated error reduction systems. While many facilities have implemented improved processes and protocols, these improvements serve to reduce the number of errors; however, according to the study, DNA matching may provide a way to prevent patient misidentification in the biopsy evaluation process.

Through the use of DNA Specimen Provenance Assignment (DSPA) and bar code technology, the know error® system brings new levels of safety and accuracy to the biopsy evaluation process. This innovative system virtually eliminates the possibililty of adverse patient outcomes due to Specimen Provenance Complications (SPC). By performing DSPA prior to treatment, the know error® system assures that SPCs will be detected prior to any unnecessary surgeries or treatment plans.

When adopted by pathology labs and their referring physicians, the know error® system dramatically reduces the incidence of SPCs enhancing patient safety and diagnostic accuracy. For more information about the know error® system, visit our website at www.knowerror.com.

Eric J. Suba,* John D. Pfeifer and Stephen S. Raab Patient Identification Error Among Prostate Needle Core Biopsy Specimens--Are We Ready for a DNA Time-Out? Journal of Urology Vol. 178, 1245-1248, October 2007